Table 1: Clinicopathological characteristics of individuals examined in this study.

All cases ( )Cases analyzed by 2DICAL ( )
PCa*( )BPH
( )
Prostatitis
( )
RCC
( )
Healthy
( )
P valuePCa* ( )Healthy
( )
P value

Age(mean ± SD)66. 3 ± 7.372.3 ± 7.565.8 ± 5.963.8 ± 8.567.2 ± 8.80.544****67.0 ± 7.265.1 ± 8.00.440****

Stage
I00
II5022
III22
IV21

TNM
classification**
T1cN0M02510
T2aN0M0157
T2bN0M021
T2cN0M084
T3aN0M022
T4N0M1b11
T4N1M1b10

PSA***ng/mL
<4211451212
4≦, ≦10301029<0.001*****143<0.001*****
10<2210090

Gleason
score
521
6157
72512
884
921
1020

Abbreviation: PCa: prostate cancer; according to TNM Classification of Malignant Tumors (International Union Against Cancer), 6th Edition; measured by Tandem R kit before the first treatment; Welch's t-test; Fisher's exact test.